Newslish
← Archive

Lesson

New Pill Doubles Survival for Pancreatic Cancer

A new daily pill, daraxonrasib, has been shown to double survival time for patients with advanced pancreatic cancer, marking a significant breakthrough in treatment.

Pick your level

StandardNatural English

Researchers have found that a daily pill named daraxonrasib can double the survival time for patients suffering from advanced pancreatic cancer. In a clinical trial involving 500 patients, those taking daraxonrasib lived an average of 13.2 months, while those receiving chemotherapy only lived between 6.6 and 6.7 months. Experts are calling this discovery a major breakthrough in cancer treatment.

Lesson audio

Standard level

Tap to play

0:24

Test your understanding

Test your understanding

01What is the name of the new pill that can double survival time for pancreatic cancer?

02How long did patients taking daraxonrasib live on average?

03What did experts call the results of the trial?

04What was the average survival time for patients receiving chemotherapy?

Discussion

Discussion

How do you think new treatments like daraxonrasib will change cancer care in the future?

Vocabulary

Vocabulary

  • survival word

    the state of continuing to live or exist

    The survival rate for patients has improved with new treatments.

  • chemotherapy word

    a type of cancer treatment using drugs

    Many patients undergo chemotherapy to fight cancer.

  • breakthrough word

    an important development or discovery

    The new drug is considered a breakthrough in cancer treatment.

  • clinical trial word

    a research study to test new treatments

    The clinical trial involved 500 patients with pancreatic cancer.

  • revolution word

    a sudden and great change

    This new treatment could lead to a revolution in cancer care.